Pharmacia & Upjohn gains Nasalcrom, PediaCare, Micatin franchises in J&J trade.
This article was originally published in The Tan Sheet
Executive Summary
PHARMACIA & UPJOHN GAINING J&J NASALCROM, PEDIACARE, MICATIN FRANCHISES in a trade up from products with small market shares for those with much greater growth potential, the company indicated June 5. Announced jointly by P&U and Johnson & Johnson, the agreement gives Pharmacia & Upjohn rights to J&J's Nasalcrom allergy product, PediaCare pediatric cough/cold, flu products and Micatin antifungal in exchange for J&J receiving full rights to the Motrin analgesic franchise and the topical antibiotic Mycitracin.